|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.045 AUD | -0.95% |
|
-6.07% | -56.46% |
| Nov. 02 | OncoSil Medical Limited Announces Retirement of Doug Cubbin as Independent Non-Executive Director | CI |
| Oct. 15 | OncoSil Medical Reports First Pancreatic Cancer Device Treatment in Germany | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ONCOSIL MEDICAL LIMITED | Other Pharmaceuticals | -0.95% | -6.07% | -56.46% | -67.34% | -98.06% | 13.79M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- OSL Stock
- Charts OncoSil Medical Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
